Member Info for johnlaycock

Roger, you want to buy now despite saying we are more likely to test 2p than 4p?

We will retest 4p this week.

Doesn't the NHS have to implement the NICE recommendation within 3 months or I have mis read that somewhere?

Also remember they will be selling our test direct to labs as well. Win Win.

Https://www.linkedin.com/posts/dhsc_medtech-activity-7225152770297790467-2oPQ?utm_source=share&utm_medium=member_android

We should hopefully have an update soon on next steps / roll out etc. They won't have been sitting idly over the last few months waiting for the final recommendation from NICE. I think August will be a busy month for the company.

This is factually correct as per the RNS on 20th Dec 23 re overseas orders being received.

Roger...we got full approval 48hrs ago and you are demanding sales! These things take time as NICE alluded to when they said they are working with NHS to develop resources etc . Patience is needed but this share price will look very different in a few weeks/ months.

Stephen thanks...do you have any insight on the July production numbers yet?

NHS you have been mandated by NICE to use a test, get in touch with Genedrive. Very smart marketing.

Https://www.linkedin.com/posts/genedrive-plc_gdr-poct-pharmacogenomics-activity-7224808755916345345-QyOH?utm_source=share&utm_medium=member_android

Stocksaint...Read his comments regarding discussions with colleagues on implementation across the country!

....discussions already started for a national roll out . See below comments from John McDermott.

https://research.cmft.nhs.uk/news-events/manchester-leads-implementation-of-lifesaving-genetic-bedside-stroke-test

A very significant sentence in the RNS which may have been overlooked by many is that the company's test is also suitable for Lab testing as a more affordable alternative to current supply.....this therefore is a win/win for Genedrive.

Https://www.nice.org.uk/guidance/dg59

Looks like project documentation has just been updated.

They will release as and when NICE update their website. They generally do this overnight so if they are sticking to their 31st July deadline we should have a 7am RNS confirming full recommendation.

If NICE weren't going to give full recommendation, they would have known this before they extended the final report until 31st July so that suggests to me all is good?

The Genedrive products will save the NHS money in the medium/long term so a no brainer from that respect.

So Slacker you think with full NICE recommendation and the fast track FDA approval process in play, the SP will fall back to the recent placing price?

Https://www.tandfonline.com/eprint/VTWMIGCYAEISA9ZRSQKX/full?target=10.1080/14622416.2024.2366691